2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
34
Insulin Resistance
6
Infertility
5
Hyperandrogenism
3
Anovulation
3
Pre-Eclampsia
2
Metabolic Syndrome
2
Infertility, Female
2
Glucose Intolerance
2
Diabetes, Gestational
2
Carcinoma, Non-Small-Cell Lung
2
Weight Loss
1
Thyroid Nodule
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Premature Birth
1
Precancerous Conditions
1
Periodontitis
1
Oligomenorrhea
1
Menstruation Disturbances
1
Lung Neoplasms
1
Inflammation
1
Hodgkin Disease
1
Colonic Neoplasms
1
Amenorrhea
1
Interventions
Musculoskeletal Manipulations
2
drospirenone and ethinyl estradiol combination
1
Tamoxifen
1
Surveys and Questionnaires
1
Radiotherapy
1
Postoperative Period
1
Metformin
1
Mastectomy, Segmental
1
Mastectomy, Modified Radical
1
Inositol
1
Flutamide
1
Epirubicin
1
Docetaxel
1
Cyproterone acetate, ethinyl estradiol drug combination
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Amenorrhea
×
Inositol
×
Clear all
NCT06800170
2026-01-06
HP-phD_Adolesc
Lo.Li.Pharma s.r.l
Phase NA
Recruiting
20 enrolled